Article Information
History
- December 6, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Evan D. Paul1,2,
- Barbora Huraiová1,2,
- Natália Valková1,2,3,
- Natalia Birknerova1,2,
- Daniela Gábrišová1,2,
- Sona Gubova1,2,
- Helena Ignačáková1,2,
- Tomáš Ondris1,2,
- Silvia Bendíková1,2,
- Jarmila Bíla1,2,
- Katarína Buranovská1,2,
- Diana Drobná1,2,
- Zuzana Krchnakova1,2,
- Maryna Kryvokhyzha1,2,
- Daniel Lovíšek1,2,
- Viktoriia Mamoilyk1,2,
- Veronika Mančíková1,2,
- Nina Vojtaššáková1,2,
- Michaela Ristová1,2,4,
- Iñaki Comino-Méndez5,
- Igor Andrašina6,
- Pavel Morozov7,
- Thomas Tuschl7,
- Fresia Pareja8,* and
- Pavol Čekan1,2,*,#
- 1MultiplexDX, s.r.o., Comenius University Science Park, Bratislava, Slovakia
- 2MultiplexDX, Inc., Rockville, MD, USA
- 3Institute of Clinical Biochemistry and Diagnostics, University Hospital, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 4Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, Scotland, UK. Electronic address: s1507601{at}ed.ac.uk
- 5Unidad de Gestión Clínica Intercentros de Oncología Medica, Hospitales Universitarios Regional y Virgen de la Victoria. The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), Málaga, Spain
- 6Department of Radiotherapy and Oncology, East Slovakia Institute of Oncology, Košice, Slovakia
- 7Laboratory for RNA Molecular Biology, The Rockefeller University, New York NY, USA
- 8Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- ↵*Corresponding author Pavol Čekan, Email: pavol{at}multiplexdx.com, telephone: +421 948 727 197; Fresia Pareja, Email: parejaf{at}mskcc.org, telephone: +1-212-639-3707